Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium.

Clemens, Eva; van den Heuvel-Eibrink, Marry M; Mulder, Renée L; Kremer, Leontien C M; Hudson, Melissa M; Skinner, Roderick; Constine, Louis S; Bass, Johnnie K; Kuehni, Claudia E; Langer, Thorsten; van Dalen, Elvira C; Bardi, Edith; Bonne, Nicolas-Xavier; Brock, Penelope R; Brooks, Beth; Carleton, Bruce; Caron, Eric; Chang, Kay W; Johnston, Karen; Knight, Kristin; ... (2019). Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium. Lancet oncology, 20(1), e29-e41. Elsevier 10.1016/S1470-2045(18)30858-1

[img] Text
Clemens LancetOncol 2019.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (720kB) | Request a copy
[img]
Preview
Text
Clemens LancetOncol 2019_manuscript.pdf - Accepted Version
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).

Download (934kB) | Preview
[img]
Preview
Text
Clemens LancetOncol 2019_manuscript_appendix.pdf - Supplemental Material
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).

Download (2MB) | Preview

Childhood, adolescent, and young adult (CAYA) cancer survivors treated with platinum-based drugs, head or brain radiotherapy, or both have an increased risk of ototoxicity (hearing loss, tinnitus, or both). To ensure optimal care and reduce consequent problems-such as speech and language, social-emotional development, and learning difficulties-for these CAYA cancer survivors, clinical practice guidelines for monitoring ototoxicity are essential. The implementation of surveillance across clinical settings is hindered by differences in definitions of hearing loss, recommendations for surveillance modalities, and remediation. To address these deficiencies, the International Guideline Harmonization Group organised an international multidisciplinary panel, including 32 experts from ten countries, to evaluate the quality of evidence for ototoxicity following platinum-based chemotherapy and head or brain radiotherapy, and formulate and harmonise ototoxicity surveillance recommendations for CAYA cancer survivors.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine
04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine

UniBE Contributor:

Kühni, Claudia and Weiss, Annette Gerda

Subjects:

600 Technology > 610 Medicine & health
300 Social sciences, sociology & anthropology > 360 Social problems & social services

ISSN:

1470-2045

Publisher:

Elsevier

Language:

English

Submitter:

Tanya Karrer

Date Deposited:

17 Jan 2019 19:38

Last Modified:

23 Oct 2019 08:27

Publisher DOI:

10.1016/S1470-2045(18)30858-1

PubMed ID:

30614474

BORIS DOI:

10.7892/boris.123508

URI:

https://boris.unibe.ch/id/eprint/123508

Actions (login required)

Edit item Edit item
Provide Feedback